• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
 

2002 Warning Letters

-

Recently Posted | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |

Tobacco Retailer Warning Letters

 

-

Warning Letters for 2002

Recently Posted | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

 
Letter Issue Date Company Name Issuing Office Subject Close Out Date
October 11, 2002 Dispensing Solutions Inc. [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 PFAB LP - Pharmafab [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 H J Harkins Co Inc. [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Allscripts Healthcare Solutions [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Compound Inc. [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 UBC Pharma Inc. [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Liberty Pharmaceuticals [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 DRX Pharmaceutical Consultants Inc. [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Alphagen Laboratories Inc. [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Respa Pharmaceuticals Inc. [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Ambi Pharmaceuticals [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Links Pharmaceutical [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Keil Laboratories Inc. [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Kaiser FDN Health Plan Colorado [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Mikart Inc [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Sage Pharmaceutical [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Wal Mart Stores Inc. [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Jerome Stevens Pharmaceuticals Inc. [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accorded New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 KV Pharmaceutical Co [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *
October 11, 2002 Pharmacy Care Plus LC [ARCHIVED] Center for Drug Evaluation and Research Certain Drugs Accord New Drug Status through Rulemaking Procedures/Guaifenesin N/A *



-
 

Contact FDA

ICECI Warning Letters

Division of Freedom of Information (HFI-35)

Food and Drug Administration

5600 Fishers Lane

Rockville, MD 20857
-
-
-
-